tiprankstipranks
Advertisement
Advertisement

DE:KUR Stock Latest News

Syndax assumed with a Buy at Jefferies
The FlySyndax assumed with a Buy at Jefferies
11d ago
KURA
SNDX
Kura Oncology price target lowered to $25 from $30 at Mizuho
PremiumThe Fly
Kura Oncology price target lowered to $25 from $30 at Mizuho
17d ago
KURA
Kura Oncology price target lowered to $15 from $16 at UBS
PremiumThe Fly
Kura Oncology price target lowered to $15 from $16 at UBS
28d ago
KURA
Kura Oncology price target raised to $30 from $29 at BofA
PremiumThe Fly
Kura Oncology price target raised to $30 from $29 at BofA
1M ago
KURA
Kura Oncology price target lowered to $36 from $38 at Wedbush
PremiumThe Fly
Kura Oncology price target lowered to $36 from $38 at Wedbush
1M ago
KURA
Kura Oncology reports inducement grants under Nasdaq listing rule
PremiumThe FlyKura Oncology reports inducement grants under Nasdaq listing rule
1M ago
KURA
Kura Oncology Earnings Call Highlights Comzifty Launch
Premium
Company Announcements
Kura Oncology Earnings Call Highlights Comzifty Launch
1M ago
KURA
Early Komzifti Traction and Clinical Catalysts Underpin Buy Rating and 2028 Growth Outlook
Premium
Ratings
Early Komzifti Traction and Clinical Catalysts Underpin Buy Rating and 2028 Growth Outlook
1M ago
KURA
Kura Oncology: Early KOMZIFTI Launch Momentum, Robust AML Data, and Strong Cash Runway Underpin Buy Rating
PremiumRatings
Kura Oncology: Early KOMZIFTI Launch Momentum, Robust AML Data, and Strong Cash Runway Underpin Buy Rating
1M ago
KURA
Kura Oncology reports Q4 EPS (92c), consensus (49c)
PremiumThe Fly
Kura Oncology reports Q4 EPS (92c), consensus (49c)
1M ago
KURA
Kura Oncology management to meet with Citizens
PremiumThe Fly
Kura Oncology management to meet with Citizens
1M ago
KURA
KURA Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-Earnings
KURA Earnings Report this Week: Is It a Buy, Ahead of Earnings?
1M ago
KURA
Kura Oncology reports inducement grants under Nasdaq listing rule
PremiumThe FlyKura Oncology reports inducement grants under Nasdaq listing rule
2M ago
KURA
Kura Oncology price target lowered to $29 from $30 at BofA
Premium
The Fly
Kura Oncology price target lowered to $29 from $30 at BofA
2M ago
KURA
Kura Oncology Tightens Governance with Amended Bylaws
Premium
Company Announcements
Kura Oncology Tightens Governance with Amended Bylaws
2M ago
8K
KURA
Kura Oncology price target lowered to $20 from $25 at Leerink
PremiumThe Fly
Kura Oncology price target lowered to $20 from $25 at Leerink
3M ago
KURA
Kura Oncology reports inducement grants under Nasdaq listing rule
PremiumThe Fly
Kura Oncology reports inducement grants under Nasdaq listing rule
3M ago
KURA
Kura Oncology’s Promising Clinical Data and Strategic Partnerships Justify Buy Rating
PremiumRatings
Kura Oncology’s Promising Clinical Data and Strategic Partnerships Justify Buy Rating
4M ago
KURA
Positive Outlook for Kura Oncology Driven by Promising Clinical Trials and Strategic Advancements
PremiumRatings
Positive Outlook for Kura Oncology Driven by Promising Clinical Trials and Strategic Advancements
4M ago
KURA
Kura Oncology, Kyowa Kirin report combination data for KOMZIFTI with ven/aza
PremiumThe FlyKura Oncology, Kyowa Kirin report combination data for KOMZIFTI with ven/aza
4M ago
KURA
Kura Oncology Announces First U.S. Sale of KOMZIFTI
Premium
Company Announcements
Kura Oncology Announces First U.S. Sale of KOMZIFTI
4M ago
8K
KURA
Kura Oncology completes first U.S. commercial sale of KOMZIFTI
Premium
The Fly
Kura Oncology completes first U.S. commercial sale of KOMZIFTI
4M ago
KURA

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >